These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 24126529

  • 1. Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity.
    Wei X, Li Y, Sun X, Zhu X, Feng Y, Liu J, Jiang Y, Shang H, Cui L, Cao Y.
    Infect Immun; 2014 Jan; 82(1):165-73. PubMed ID: 24126529
    [Abstract] [Full Text] [Related]

  • 2. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
    Du Y, Chen G, Zhang X, Yu C, Cao Y, Cui L.
    Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulation.
    Kuehlwein JM, Borsche M, Korir PJ, Risch F, Mueller AK, Hübner MP, Hildner K, Hoerauf A, Dunay IR, Schumak B.
    Immunology; 2020 Feb; 159(2):193-204. PubMed ID: 31631339
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of Plasmodium berghei Infection.
    Yi H, Jiang W, Yang F, Li F, Li Y, Zhu W, Li Q, Fakhar SH, Cao Y, Luo L, Zhang W, He Y.
    Front Immunol; 2021 Feb; 12():719189. PubMed ID: 34456927
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO, Arroja MM, Rocha JP, Fernandes AM, Barateiro AP, Brites DM, Pinto RM, Sepodes BM, Mota-Filipe HD.
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [Abstract] [Full Text] [Related]

  • 13. Targeting Toll-like receptors by chloroquine protects mice from experimental cerebral malaria.
    Zhu X, Pan Y, Li Y, Jiang Y, Shang H, Gowda DC, Cui L, Cao Y.
    Int Immunopharmacol; 2012 Aug; 13(4):392-7. PubMed ID: 22659438
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
    Ding Y, Xu W, Zhou T, Liu T, Zheng H, Fu Y.
    Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
    Wang Y, Zhang ZG, Rhodes K, Renzi M, Zhang RL, Kapke A, Lu M, Pool C, Heavner G, Chopp M.
    Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.